Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy

NCT05052398 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG: PSP NEURO SERUM
DRUG: Placebo PSP NEURO SERUM

Sponsor

Algenis SpA

Collaborators

[object Object]